Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
279 | 3 | ANGIOGENESIS//LYMPHANGIOGENESIS//VEGF | 43269 |
379 | 2 | LYMPHANGIOGENESIS//ANGIOGENESIS//VEGF | 17562 |
5541 | 1 | ENDOSTATIN//ANGIOSTATIN//COLLAGEN XVIII | 1640 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ENDOSTATIN | authKW | 4316305 | 23% | 59% | 383 |
2 | ANGIOSTATIN | authKW | 1163113 | 8% | 49% | 124 |
3 | COLLAGEN XVIII | authKW | 684619 | 3% | 76% | 47 |
4 | TUMSTATIN | authKW | 528880 | 2% | 81% | 34 |
5 | RECOMBINANT HUMAN ENDOSTATIN | authKW | 452658 | 2% | 67% | 35 |
6 | ENDOSTAR | authKW | 430654 | 3% | 55% | 41 |
7 | KNOBLOCH SYNDROME | authKW | 282991 | 1% | 82% | 18 |
8 | PLASMINOGEN KRINGLE 5 | authKW | 174688 | 1% | 91% | 10 |
9 | CANSTATIN | authKW | 145627 | 1% | 63% | 12 |
10 | ANTI ANGIOGENESIS | authKW | 138682 | 6% | 7% | 98 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 6333 | 33% | 0% | 543 |
2 | Medicine, Research & Experimental | 1275 | 11% | 0% | 188 |
3 | Biochemistry & Molecular Biology | 1144 | 25% | 0% | 410 |
4 | Cell Biology | 678 | 12% | 0% | 200 |
5 | Biotechnology & Applied Microbiology | 510 | 9% | 0% | 145 |
6 | Genetics & Heredity | 262 | 7% | 0% | 109 |
7 | Biophysics | 247 | 5% | 0% | 90 |
8 | Ophthalmology | 124 | 3% | 0% | 49 |
9 | Peripheral Vascular Diseases | 111 | 3% | 0% | 52 |
10 | Hematology | 103 | 3% | 0% | 53 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | AGEN UNIT | 103184 | 2% | 15% | 35 |
2 | CELL SIGNALING TUMOR ANGIOGENESIS | 98823 | 0% | 86% | 6 |
3 | BEIJING PROT THER EUT | 67234 | 1% | 25% | 14 |
4 | ENGN ANTITUMOR PROT THER EUT | 59603 | 1% | 28% | 11 |
5 | NANJING STAMOTOL HOSP | 43234 | 0% | 75% | 3 |
6 | ENZYME CHEM BIOCHEM | 38432 | 0% | 100% | 2 |
7 | CELL SIGNALING ANGIOGENESIS | 25620 | 0% | 67% | 2 |
8 | JIANGSU ENGN CANC BIOTHER Y | 25620 | 0% | 67% | 2 |
9 | TUMOR TARGETING GRP | 25616 | 0% | 33% | 4 |
10 | CNRS UP A 6021 | 24703 | 0% | 43% | 3 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER GENE THERAPY | 6600 | 2% | 1% | 26 |
2 | MATRIX BIOLOGY | 3076 | 1% | 1% | 15 |
3 | CANCER RESEARCH | 2502 | 4% | 0% | 73 |
4 | GENE THERAPY | 1213 | 1% | 0% | 16 |
5 | PROTEIN EXPRESSION AND PURIFICATION | 1006 | 1% | 0% | 16 |
6 | ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH | 927 | 0% | 1% | 4 |
7 | MOLECULAR CANCER THERAPEUTICS | 872 | 1% | 0% | 14 |
8 | CLINICAL CANCER RESEARCH | 805 | 2% | 0% | 26 |
9 | ACTA BIOCHIMICA ET BIOPHYSICA SINICA | 803 | 1% | 0% | 11 |
10 | INTERNATIONAL JOURNAL OF CANCER | 740 | 2% | 0% | 29 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENDOSTATIN | 4316305 | 23% | 59% | 383 | Search ENDOSTATIN | Search ENDOSTATIN |
2 | ANGIOSTATIN | 1163113 | 8% | 49% | 124 | Search ANGIOSTATIN | Search ANGIOSTATIN |
3 | COLLAGEN XVIII | 684619 | 3% | 76% | 47 | Search COLLAGEN+XVIII | Search COLLAGEN+XVIII |
4 | TUMSTATIN | 528880 | 2% | 81% | 34 | Search TUMSTATIN | Search TUMSTATIN |
5 | RECOMBINANT HUMAN ENDOSTATIN | 452658 | 2% | 67% | 35 | Search RECOMBINANT+HUMAN+ENDOSTATIN | Search RECOMBINANT+HUMAN+ENDOSTATIN |
6 | ENDOSTAR | 430654 | 3% | 55% | 41 | Search ENDOSTAR | Search ENDOSTAR |
7 | KNOBLOCH SYNDROME | 282991 | 1% | 82% | 18 | Search KNOBLOCH+SYNDROME | Search KNOBLOCH+SYNDROME |
8 | PLASMINOGEN KRINGLE 5 | 174688 | 1% | 91% | 10 | Search PLASMINOGEN+KRINGLE+5 | Search PLASMINOGEN+KRINGLE+5 |
9 | CANSTATIN | 145627 | 1% | 63% | 12 | Search CANSTATIN | Search CANSTATIN |
10 | ANTI ANGIOGENESIS | 138682 | 6% | 7% | 98 | Search ANTI+ANGIOGENESIS | Search ANTI+ANGIOGENESIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |